Microarray data mining for potential selenium targets in chemoprevention of prostate cancer

Haitao Zhang, Yan Dong, Hongjuan Zhao, James D. Brooks, Lesleyann Hawthorn, Norma Nowak, James R. Marshall, Allen C. Gao, Clement Ip

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: A previous clinical trial showed that selenium supplementation significantly reduced the incidence of prostate cancer. We report here a bioinformatics approach to gain new insights into selenium molecular targets that might be relevant to prostate cancer chemoprevention. Materials and Methods: We first performed data mining analysis to identify genes which are consistently dysregulated in prostate cancer using published datasets from gene expression profiling of clinical prostate specimens. We then devised a method to systematically analyze three selenium microarray datasets from the LNCaP human prostate cancer cells, and to match the analysis to the cohort of genes implicated in prostate carcinogenesis. Moreover, we compared the selenium datasets with two datasets obtained from expression profiling of androgen-stimulated LNCaP cells. Results: We found that selenium reverses the expression of genes implicated in prostate carcinogenesis. In addition, we found that selenium could counteract the effect ofandrogen on the expression of a subset obtained from androgen-regulated genes. Conclusions: The above information provides us with a treasure of new clues to investigate the mechanism of selenium chemoprevention of prostate cancer. Furthermore, these selenium target genes could also serve as biomarkers in future clinical trials to gauge the efficacy of selenium intervention.

Original languageEnglish (US)
Pages (from-to)97-113
Number of pages17
JournalCancer Genomics and Proteomics
Volume2
Issue number2
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Data Mining
Chemoprevention
Microarrays
Selenium
Data mining
Prostatic Neoplasms
Genes
Prostate
Androgens
Carcinogenesis
Clinical Trials
Gene Expression Profiling
Biomarkers
Bioinformatics
Computational Biology
Gene expression
Gages
Cohort Studies
Cells
Gene Expression

Keywords

  • Androgen receptor
  • Chemoprevention
  • Prostate carcinogenesis
  • Selenium

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Zhang, H., Dong, Y., Zhao, H., Brooks, J. D., Hawthorn, L., Nowak, N., ... Ip, C. (2005). Microarray data mining for potential selenium targets in chemoprevention of prostate cancer. Cancer Genomics and Proteomics, 2(2), 97-113.

Microarray data mining for potential selenium targets in chemoprevention of prostate cancer. / Zhang, Haitao; Dong, Yan; Zhao, Hongjuan; Brooks, James D.; Hawthorn, Lesleyann; Nowak, Norma; Marshall, James R.; Gao, Allen C.; Ip, Clement.

In: Cancer Genomics and Proteomics, Vol. 2, No. 2, 01.01.2005, p. 97-113.

Research output: Contribution to journalArticle

Zhang, H, Dong, Y, Zhao, H, Brooks, JD, Hawthorn, L, Nowak, N, Marshall, JR, Gao, AC & Ip, C 2005, 'Microarray data mining for potential selenium targets in chemoprevention of prostate cancer', Cancer Genomics and Proteomics, vol. 2, no. 2, pp. 97-113.
Zhang, Haitao ; Dong, Yan ; Zhao, Hongjuan ; Brooks, James D. ; Hawthorn, Lesleyann ; Nowak, Norma ; Marshall, James R. ; Gao, Allen C. ; Ip, Clement. / Microarray data mining for potential selenium targets in chemoprevention of prostate cancer. In: Cancer Genomics and Proteomics. 2005 ; Vol. 2, No. 2. pp. 97-113.
@article{5017727b71294e23a1525e85ca4a294f,
title = "Microarray data mining for potential selenium targets in chemoprevention of prostate cancer",
abstract = "Background: A previous clinical trial showed that selenium supplementation significantly reduced the incidence of prostate cancer. We report here a bioinformatics approach to gain new insights into selenium molecular targets that might be relevant to prostate cancer chemoprevention. Materials and Methods: We first performed data mining analysis to identify genes which are consistently dysregulated in prostate cancer using published datasets from gene expression profiling of clinical prostate specimens. We then devised a method to systematically analyze three selenium microarray datasets from the LNCaP human prostate cancer cells, and to match the analysis to the cohort of genes implicated in prostate carcinogenesis. Moreover, we compared the selenium datasets with two datasets obtained from expression profiling of androgen-stimulated LNCaP cells. Results: We found that selenium reverses the expression of genes implicated in prostate carcinogenesis. In addition, we found that selenium could counteract the effect ofandrogen on the expression of a subset obtained from androgen-regulated genes. Conclusions: The above information provides us with a treasure of new clues to investigate the mechanism of selenium chemoprevention of prostate cancer. Furthermore, these selenium target genes could also serve as biomarkers in future clinical trials to gauge the efficacy of selenium intervention.",
keywords = "Androgen receptor, Chemoprevention, Prostate carcinogenesis, Selenium",
author = "Haitao Zhang and Yan Dong and Hongjuan Zhao and Brooks, {James D.} and Lesleyann Hawthorn and Norma Nowak and Marshall, {James R.} and Gao, {Allen C.} and Clement Ip",
year = "2005",
month = "1",
day = "1",
language = "English (US)",
volume = "2",
pages = "97--113",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Microarray data mining for potential selenium targets in chemoprevention of prostate cancer

AU - Zhang, Haitao

AU - Dong, Yan

AU - Zhao, Hongjuan

AU - Brooks, James D.

AU - Hawthorn, Lesleyann

AU - Nowak, Norma

AU - Marshall, James R.

AU - Gao, Allen C.

AU - Ip, Clement

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Background: A previous clinical trial showed that selenium supplementation significantly reduced the incidence of prostate cancer. We report here a bioinformatics approach to gain new insights into selenium molecular targets that might be relevant to prostate cancer chemoprevention. Materials and Methods: We first performed data mining analysis to identify genes which are consistently dysregulated in prostate cancer using published datasets from gene expression profiling of clinical prostate specimens. We then devised a method to systematically analyze three selenium microarray datasets from the LNCaP human prostate cancer cells, and to match the analysis to the cohort of genes implicated in prostate carcinogenesis. Moreover, we compared the selenium datasets with two datasets obtained from expression profiling of androgen-stimulated LNCaP cells. Results: We found that selenium reverses the expression of genes implicated in prostate carcinogenesis. In addition, we found that selenium could counteract the effect ofandrogen on the expression of a subset obtained from androgen-regulated genes. Conclusions: The above information provides us with a treasure of new clues to investigate the mechanism of selenium chemoprevention of prostate cancer. Furthermore, these selenium target genes could also serve as biomarkers in future clinical trials to gauge the efficacy of selenium intervention.

AB - Background: A previous clinical trial showed that selenium supplementation significantly reduced the incidence of prostate cancer. We report here a bioinformatics approach to gain new insights into selenium molecular targets that might be relevant to prostate cancer chemoprevention. Materials and Methods: We first performed data mining analysis to identify genes which are consistently dysregulated in prostate cancer using published datasets from gene expression profiling of clinical prostate specimens. We then devised a method to systematically analyze three selenium microarray datasets from the LNCaP human prostate cancer cells, and to match the analysis to the cohort of genes implicated in prostate carcinogenesis. Moreover, we compared the selenium datasets with two datasets obtained from expression profiling of androgen-stimulated LNCaP cells. Results: We found that selenium reverses the expression of genes implicated in prostate carcinogenesis. In addition, we found that selenium could counteract the effect ofandrogen on the expression of a subset obtained from androgen-regulated genes. Conclusions: The above information provides us with a treasure of new clues to investigate the mechanism of selenium chemoprevention of prostate cancer. Furthermore, these selenium target genes could also serve as biomarkers in future clinical trials to gauge the efficacy of selenium intervention.

KW - Androgen receptor

KW - Chemoprevention

KW - Prostate carcinogenesis

KW - Selenium

UR - http://www.scopus.com/inward/record.url?scp=20344379480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344379480&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:20344379480

VL - 2

SP - 97

EP - 113

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 2

ER -